Allen Andrew R
Insider CIK 1374539 · SRRA Director, 10% owner · CLVS See Remarks · EPZM Director · ADAP Director · GRTS President and CEO, Director · TCRR Director · CGEM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2026-06-16 | 2026-06-18 | 21,781 | — | $0 | 21,781 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2025-08-07 | 2025-08-08 | 79,456 | — | $0 | 79,456 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-07-01 | 2024-07-01 | 660,000 | — | $0 | 660,000 | SEC↗ |
| GRTS Gritstone bio, Inc. | G Gift | 2024-06-24 | 2024-06-26 | 325,000 | — | $0 | 1,124,275 | SEC↗ |
| GRTS Gritstone bio, Inc. | G Gift | 2024-06-24 | 2024-06-26 | 325,000 | — | $0 | 985,360 | SEC↗ |
| GRTS Gritstone bio, Inc. | S Sale | 2024-05-16 | 2024-05-17 | 24,263 | $0.75 | $18.2K | 985,360 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award deriv | 2024-05-15 | 2024-05-17 | 615,000 | — | $0 | 615,000 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award | 2024-05-15 | 2024-05-17 | 47,873 | — | $0 | 1,009,623 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 615,000 | — | $0 | 615,000 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award | 2024-02-01 | 2024-02-05 | 105,000 | — | $0 | 899,345 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 73,212 | — | $0 | 73,212 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 45,348 | — | $0 | 45,348 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 109,746 | — | $0 | 109,746 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 109,746 | — | $0 | 109,746 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 152,376 | — | $0 | 152,376 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-05 | 2023-07-05 | 56,868 | — | $0 | 56,868 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-03 | 2023-07-03 | 500,000 | — | $0 | 500,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 5,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 6,270 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 8,072 | — | $0 | 0 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award | 2023-02-02 | 2023-02-06 | 738,550 | — | $0 | 856,750 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-12-15 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 12,030 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 750 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,250 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 625 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 6,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 1,650 | $55.00 | $90.8K | 0 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award deriv | 2022-01-31 | 2022-04-20 | 410,000 | — | $0 | 410,000 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award | 2022-01-31 | 2022-04-20 | 70,000 | — | $0 | 118,200 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 40,559 | — | $0 | 40,559 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-06-11 | 2021-06-15 | 8,060 | — | $0 | 20,560 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2021-06-08 | 2021-06-09 | 6,000 | — | $0 | 6,000 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2021-03-08 | 2021-03-10 | 290,000 | — | $0 | 290,000 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award | 2021-01-07 | 2021-11-19 | 48,200 | — | $0 | 48,200 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2020-12-10 | 2020-12-11 | 12,100 | — | $0 | 12,100 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2020-06-09 | 2020-06-10 | 12,030 | — | $0 | 12,030 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 14,013 | — | $0 | 14,013 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2020-03-16 | 2020-03-18 | 12,500 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2020-03-16 | 2020-03-18 | 12,500 | $9.33 | $116.6K | 12,500 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 275,000 | — | $0 | 275,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-12-19 | 2019-12-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2019-06-11 | 2019-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2019-05-31 | 2019-06-07 | 17,633 | — | $0 | 17,633 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-04-11 | 2019-04-12 | 6,270 | — | $0 | 6,270 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2019-02-13 | 2019-03-14 | 180,000 | — | $0 | 180,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2018-12-10 | 2018-12-11 | 66,000 | $1.64 | $108.2K | 66,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-05-18 | 2018-05-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2017-11-10 | 2017-11-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2017-06-22 | 2017-06-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2016-05-19 | 2016-05-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2015-07-08 | 2015-07-10 | 7,333 | — | $0 | 7,333 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2015-03-02 | 2015-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-01-16 | 2015-01-20 | 49,176 | $65.88 | $3.24M | 101,919 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-01-16 | 2015-01-20 | 30,524 | $65.27 | $1.99M | 151,095 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-01-16 | 2015-01-21 | 49,176 | $66.26 | $3.26M | 101,919 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-01-16 | 2015-01-21 | 30,524 | $65.27 | $1.99M | 151,095 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-01-15 | 2015-01-20 | 300 | $65.00 | $19.5K | 181,619 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-01-15 | 2015-01-21 | 300 | $65.00 | $19.5K | 181,619 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2014-06-09 | 2014-06-11 | 17,666 | — | $0 | 17,666 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2014-01-10 | 2014-01-14 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-05 | 2013-06-07 | 5,800 | $70.06 | $406.3K | 2,600 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-05 | 2013-06-07 | 2,600 | $70.72 | $183.9K | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-05 | 2013-06-07 | 2,500 | $68.84 | $172.1K | 8,400 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-05 | 2013-06-07 | 700 | $65.77 | $46.0K | 21,894 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-05 | 2013-06-07 | 6,494 | $67.65 | $439.3K | 10,900 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-05 | 2013-06-07 | 4,500 | $66.89 | $301.0K | 17,394 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2013-03-01 | 2013-03-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |